↓ Skip to main content

COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis

Overview of attention for article published in BMC Cancer, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
37 Mendeley
Title
COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis
Published in
BMC Cancer, June 2014
DOI 10.1186/1471-2407-14-458
Pubmed ID
Authors

Ewa Pomianowska, Aasa R Schjølberg, Ole Petter F Clausen, Ivar P Gladhaug

Abstract

Overexpression of cyclooxygenase-2 (COX-2) has been implicated in oncogenesis and progression of adenocarcinomas of the pancreatic head. The data on the prognostic importance of COX expression in these tumours is inconsistent and conflicting. We evaluated how COX-2 overexpression affected overall postoperative survival in pancreatic head adenocarcinomas.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Unknown 35 95%

Demographic breakdown

Readers by professional status Count As %
Other 2 5%
Researcher 2 5%
Student > Doctoral Student 1 3%
Student > Ph. D. Student 1 3%
Student > Bachelor 1 3%
Other 2 5%
Unknown 28 76%
Readers by discipline Count As %
Medicine and Dentistry 7 19%
Nursing and Health Professions 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Unknown 28 76%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#14,783,222
of 22,759,618 outputs
Outputs from BMC Cancer
#3,662
of 8,277 outputs
Outputs of similar age
#127,667
of 228,321 outputs
Outputs of similar age from BMC Cancer
#61
of 140 outputs
Altmetric has tracked 22,759,618 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,277 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,321 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.